DISEASE SCANNER
Global Incurable Diseases Tracker
Oculopharyngeal Muscular Dystrophy (OPMD)
A late-onset muscular dystrophy characterized by ptosis (drooping eyelids) and dysphagia (difficulty swallowing). Caused by GCG repeat expansion in PABPN1 gene. Onset typically 40-60 years. More common in certain populations (French-Canadian, Bukhara Jews).
100.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Genetic testing
- 2Clinical evaluation
- 3Family history assessment
- 4Specialized laboratory tests
- 5Imaging studies
- 6Biopsy (if applicable)
Prognosis
Slowly progressive condition with normal life expectancy. Ptosis and dysphagia are main manifestations. Dysphagia may require dietary modifications or cricopharyngeal myotomy. Ptosis surgery is often needed but may need repeat procedures. Proximal limb weakness develops later in disease course. Most patients remain ambulatory throughout life. Onset typically in 40s-50s; earlier onset correlates with more severe course. Genetic counseling for autosomal dominant inheritance.
Prevention
- Genetic counseling
- Carrier screening
- Prenatal diagnosis
- Preimplantation genetic diagnosis
- Family planning
Research Status
Cricopharyngeal myotomy for dysphagia. Eyelid surgery for ptosis. Supportive care. No disease-modifying therapy. Progression is slow; most maintain mobility. Good prognosis with supportive care.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK1116
- https://medlineplus.gov/genetics
- https://rarediseases.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.